Amp Ltd. Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Amp Ltd. in den nächsten Jahren?
Pro
?
U****************
?
M****
?
M************
Kontra
?
A****************
?
L*********** I********** f** d** n******* J****
?
W******* i* V********
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Amp Ltd. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Amp Ltd. | 3,15 % | -0,78 % | 23,30 % | 41,11 % | 23,30 % | 98,44 % | 95,38 % |
| National Australia Bank | 3,84 % | -0,36 % | 6,91 % | 17,66 % | 5,24 % | 49,98 % | 52,79 % |
| Commonwealth Bank Australia | 0,51 % | 2,32 % | 8,20 % | 13,40 % | 20,32 % | 80,59 % | 75,48 % |
| Macquarie Group Ltd | 2,19 % | -1,04 % | -0,10 % | 32,49 % | 33,93 % | 49,46 % | 58,92 % |
Kommentare
News
Ardagh Metal Packaging Q2 Earnings Call Highlights
Key Points
- Interested in Ardagh Metal Packaging S.A.? Here are five stocks we like better.
- Ardagh Metal Packaging raised full-year 2026 adjusted EBITDA guidance to $775 million-$790 million
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth
Key Points
- Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amphastar is shifting its strategy from complex generics toward proprietary drugs and
Pennon Group H2 Earnings Call Highlights
Key Points
- Interested in Pennon Group Plc? Here are five stocks we like better.
- Pennon returned to profitability in 2025/2026, with EBITDA up 55% and underlying operating profit more than